Journal
EXPERT REVIEW OF PROTEOMICS
Volume 10, Issue 3, Pages 259-273Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1586/EPR.13.19
Keywords
clinical proteomics; imaging mass spectrometry; MALDI imaging mass spectrometry; molecular pathology; tissue protein analysis
Categories
Funding
- BMBF [0315508A, 01IB10004E]
- Deutsche Forschungsgemeinschaft [SFB 824 TP B1, SFB 824 TP Z2, WA 1656/3-1]
Ask authors/readers for more resources
Imaging mass spectrometry (IMS) is still a relatively young imaging technique that allows molecular mapping of diverse biomolecules in their natural environment. Furthermore, IMS allows for the direct correlation of tissue histology and proteomic, metabolomic or lipidomic information. In recent years, increasing efforts have been made in the development and improvement of IMS, which aid its application in clinical research. In this article, current frontiers of clinical research applications of IMS are discussed in the context of recent developments of IMS technology. Critical stages in planning and realizing clinical studies are highlighted. Finally, a selection of recent prominent examples for successful clinical applications of IMS is presented.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available